Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.
Recce Pharmaceuticals Ltd has announced the appointment of BDO Audit Pty Ltd as its new auditor, following the resignation of the previous auditor, BDO Audit (WA) Pty Ltd, and subsequent approval from ASIC. The change was necessitated by an internal restructuring within BDO. The company, known for developing innovative synthetic anti-infectives targeting antibiotic-resistant superbugs and viral pathogens, continues to progress with its notable pipeline, including products recognized by the WHO and FDA for addressing global health threats.
For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.
